Sunnybrook Health Sciences Centre

Running trials

• Recruiting

  Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)

  NCT07191145· Phase 3· Source

• Recruiting

  Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

  NCT07454707· Phase 3· Source

• Not yet recruiting

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· Phase 3· Source

• Recruiting

  Ketogenic Diet and Neuromodulation in Treatment Resistant Depression

  NCT07376018· Source

• Not yet recruiting

  CEST for Prostate Biopsy

  NCT07785024· Source

• Recruiting

  Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)

  NCT07434791· Source

• Recruiting

  Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)

  NCT07576647· Source

• Recruiting

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· Phase 3· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  NCT07644559· Phase 2· Source

• Not yet recruiting

  Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke

  NCT07590076· Source

• Recruiting

  InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression

  NCT06781697· Phase 3· Source

• Not yet recruiting

  A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

  NCT07512076· Phase 2· Source

• Recruiting

  Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares

  NCT07245732· Phase 4· Source

• Active, not recruiting

  Dose-dEscalated MR-Guided Radiotherapy for Localized Prostate Cancer

  NCT07674225· Source

• Recruiting

  A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

  NCT07369076· Phase 1/2· Source

• Not yet recruiting

  Sustained Mood Improvement With Laughing Gas Exposure

  NCT07262008· Phase 3· Source

• Active, not recruiting

  A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07170150· Phase 3· Source

• Recruiting

  Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma

  NCT07476794· Phase 2· Source

• Recruiting

  Levetiracetam for Persons at Risk for Alzheimer's Disease

  NCT07477431· Phase 2· Source

• Recruiting

  The Multicentre Selective Lymphadenectomy Trial - 3

  NCT07049276· Source

• Recruiting

  A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  NCT07114601· Phase 1· Source

• Recruiting

  rTMS for Youth Inpatients With Depression

  NCT07140575· Source

• Recruiting

  Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Anorexia Nervosa With Comorbid Obsessive Compulsive Disorder or Major Depressive Disorder

  NCT07113665· Phase 1· Source

• Recruiting

  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  NCT06943755· Phase 2/3· Source

• Recruiting

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  NCT06963827· Phase 3· Source

• Recruiting

  Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression

  NCT07094789· Source

• Recruiting

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· Phase 3· Source

• Recruiting

  Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression

  NCT07108257· Source

• Recruiting

  Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)

  NCT07002450· Source

• Recruiting

  Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

  NCT07179328· Phase 1· Source

• Recruiting

  A Randomized Neuroimaging Trial of Psilocybin in Depression

  NCT06072898· Phase 2· Source

• Recruiting

  Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

  NCT06626022· Phase 3· Source

• Recruiting

  Life Following Excision of Neuroendocrine Tumors

  NCT06981455· Source

• Recruiting

  A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

  NCT06827236· Phase 1/2· Source

• Active, not recruiting

  Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)

  NCT07193953· Phase 1· Source

• Recruiting

  A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  NCT06790693· Phase 3· Source

• Recruiting

  The HEROES Trial: Hyperbaric Oxygen Therapy for Endometriosis-Related Pain

  NCT06579040· Source

• Recruiting

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

  NCT06801834· Phase 3· Source

• Recruiting

  Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression

  NCT06854367· Source

• Recruiting

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· Phase 3· Source

• Not yet recruiting

  CPAP Randomized Controlled Trial

  NCT06773416· Source

• Recruiting

  Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions

  NCT06638541· Source

• Recruiting

  Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible

  NCT06055257· Phase 3· Source

• Recruiting

  qEEG Brain Signature of Depression & Neuromodulation-induced Recovery

  NCT06719427· Phase 1· Source

• Recruiting

  Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  NCT06736574· Phase 3· Source

• Recruiting

  A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  NCT05552157· Phase 2/3· Source

• Recruiting

  A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  NCT06647498· Phase 2/3· Source

• Recruiting

  PULSED AF Post-Approval Study

  NCT06578104· Source

• Recruiting

  NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy

  NCT06403267· Phase 2· Source

• Active, not recruiting

  A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

  NCT06190951· Phase 2· Source

Showing 50 of 150.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression12 recruiting
• Alzheimer disease11 recruiting
• Prostate cancer11 recruiting
• Childhood cancers10 recruiting
• Metastatic breast cancer10 recruiting
• Head and neck cancer4 recruiting
• Melanoma4 recruiting
• Stroke4 recruiting
• Atrial fibrillation3 recruiting
• Colorectal cancer3 recruiting
• Coronary artery disease3 recruiting
• Frontotemporal dementia3 recruiting
• Glioblastoma3 recruiting
• Neuroendocrine tumours3 recruiting
• Pancreatic cancer3 recruiting
• ALS (motor neurone disease)2 recruiting
• Bipolar disorder2 recruiting
• Gastric and oesophageal cancer2 recruiting
• Heart failure2 recruiting
• Lewy body dementia2 recruiting
• Lung cancer2 recruiting
• Acute myeloid leukaemia1 recruiting
• Cervical cancer1 recruiting
• Chronic kidney disease1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Endometriosis1 recruiting
• High blood pressure1 recruiting
• IgA nephropathy1 recruiting
• Migraine1 recruiting
• Myelodysplastic syndromes1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Parkinson disease1 recruiting
• Rheumatoid arthritis1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

  NCT06926660· Phase 2· Source

• Completed

  FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)

  NCT06451042· Source

• Terminated

  Continuation Study for Latozinemab

  NCT06111014· Phase 3· Source

• Terminated

  Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

  NCT05860296· Phase 1/2· Source

• Terminated

  Nabilone for Agitation in Frontotemporal Dementia

  NCT05742698· Phase 2· Source

• Completed

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· Phase 3· Source

• Completed

  TESTING -ON Post-Trial ObservatioNal Cohort Study

  NCT05434325· Source

• Terminated

  Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma

  NCT05472766· Source

• Completed

  Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

  NCT05107882· Source

• Terminated

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· Phase 3· Source

• Completed

  Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI

  NCT05220501· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Source

• Completed

  UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial

  NCT04726397· Source

• Completed

  Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM

  NCT04440358· Phase 1/2· Source

• Completed

  A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

  NCT03987295· Phase 2· Source

• Completed

  Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

  NCT03941093· Phase 3· Source

• Completed

  Using Exercise and Electrical Brain Stimulation to Improve Memory in Dementia

  NCT03670615· Source

• Completed

  Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma

  NCT03616860· Source

• Completed

  This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)

  NCT03599245· Phase 3· Source

• Completed

  Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

  NCT03048825· Phase 3· Source

• Completed

  Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

  NCT03268954· Phase 3· Source

• Completed

  Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

  NCT03269994· Phase 3· Source

• Completed

  A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma

  NCT03274492· Phase 3· Source

• Completed

  Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary Hypertension

  NCT04402645· Source

• Completed

  Alzheimer's Disease Neuroimaging Initiative 3

  NCT02854033· Source

• Completed

  Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver

  NCT02724540· Phase 2· Source

• Completed

  Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

  NCT02168829· Phase 4· Source

• Recruiting

  JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

  NCT02468024· Phase 3· Source

• Completed

  A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

  NCT02398656· Phase 3· Source

• Completed

  Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease

  NCT02330510· Source

• Terminated

  Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

  NCT02085265· Phase 2· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Source

• Completed

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· Phase 3· Source

• Completed

  Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery

  NCT01842568· Source

• Completed

  A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma

  NCT01650701· Phase 3· Source

• Completed

  Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

  NCT00673842· Phase 3· Source